Childhood anxiety disorders can and should be treated, according to UT Southwestern national expert

December 24, 2008

DALLAS - Dec. 24, 2008 - Anxiety disorders in children and adolescents should be recognized and treated to prevent educational underachievement and adult substance abuse, anxiety disorders and depression, says a nationally recognized child psychiatrist from UT Southwestern Medical Center.

In an editorial appearing in the Dec. 25 issue of New England Journal of Medicine, Dr. Graham Emslie, professor of psychiatry and pediatrics at UT Southwestern, urges awareness that children need to be treated for anxiety disorders and recommends that related empirical evidence be integrated into treatment guidelines.

"Anxiety disorders may cause children to avoid social situations and age-appropriate developmental milestones," said Dr. Emslie. "Further, the avoidance cycle can lead to less opportunity to develop social skills necessary for success later in life. Treatment would help children learn healthy coping skills."

Up to 20 percent of children and adolescents are affected by persistent and excessive worry that can manifest as generalized anxiety disorder, separation anxiety disorder and social phobia. Research has shown that failure to identify these disorders early leads to educational underachievement and increased rates of anxiety disorders, depression and substance abuse later in life.

Only with the adaptation of the Diagnostic and Statistical Manual of Mental Disorders 4th edition did the mental health community recognize that adult anxiety disorders have origins in childhood, wrote Dr. Emslie, the first psychiatrist to demonstrate that antidepressants are effective in depressed children and adolescents.

Anxiety disorders in children are frequently unrecognized because they may only report physical aches and may be unable to verbalize "worry" or "fear," said Dr. Emslie, chief of child and adolescent psychiatry at Children's Medical Center Dallas.

The editorial accompanies a study in the same issue of the journal by senior author John Walkup of Johns Hopkins Medical Institute. The pivotal research, which was conducted at seven medical institutions across the U.S., was the first study to directly compare medication treatment, cognitive behavioral therapy that examines thinking patterns in order to modify behavior, and the combination of both treatments in children and teens with anxiety disorders. The results showed that antidepressant medications and cognitive behavioral therapy were equally effective treatments for anxiety and that the combination of both treatments was most effective.

Dr. Emslie said he hopes future studies will build on this work to determine what type to treatment is best for individual patients.

"Partial treatment is not adequate," he said. "If children aren't treated to the point of complete remission, they are likely to relapse. It's imperative that we help children overcome their anxiety disorders for their own lifetime good."
-end-
This news release is available on our World Wide Web home page at http://www.utsouthwestern.edu/home/news/index.html

To automatically receive news releases from UT Southwestern via e-mail, subscribe at http://www.utsouthwestern.edu/receivenews

Dr. Graham Emslie -- http://www.utsouthwestern.edu/findfac/professional/0,2356,12044,00.html

UT Southwestern Medical Center

Related Depression Articles from Brightsurf:

Children with social anxiety, maternal history of depression more likely to develop depression
Although researchers have known for decades that depression runs in families, new research from Binghamton University, State University of New York, suggests that children suffering from social anxiety may be at particular risk for depression in the future.

Depression and use of marijuana among US adults
This study examined the association of depression with cannabis use among US adults and the trends for this association from 2005 to 2016.

Maternal depression increases odds of depression in offspring, study shows
Depression in mothers during and after pregnancy increased the odds of depression in offspring during adolescence and adulthood by 70%.

Targeting depression: Researchers ID symptom-specific targets for treatment of depression
For the first time, physician-scientists at Beth Israel Deaconess Medical Center have identified two clusters of depressive symptoms that responded to two distinct neuroanatomical treatment targets in patients who underwent transcranial magnetic brain stimulation (TMS) for treatment of depression.

A biological mechanism for depression
Researchers report that in depressed individuals there are increased amounts of an unmodified structural protein, called tubulin, in lipid rafts compared with non-depressed individuals.

Depression in adults who are overweight or obese
In an analysis of primary care records of 519,513 UK adults who were overweight or obese between 2000-2016 and followed up until 2019, the incidence of new cases of depression was 92 per 10,000 people per year.

Why stress doesn't always cause depression
Rats susceptible to anhedonia, a core symptom of depression, possess more serotonin neurons after being exposed to chronic stress, but the effect can be reversed through amygdala activation, according to new research in JNeurosci.

Which comes first: Smartphone dependency or depression?
New research suggests a person's reliance on his or her smartphone predicts greater loneliness and depressive symptoms, as opposed to the other way around.

Depression breakthrough
Major depressive disorder -- referred to colloquially as the 'black dog' -- has been identified as a genetic cause for 20 distinct diseases, providing vital information to help detect and manage high rates of physical illnesses in people diagnosed with depression.

CPAP provides relief from depression
Researchers have found that continuous positive airway pressure (CPAP) treatment of obstructive sleep apnea (OSA) can improve depression symptoms in patients suffering from cardiovascular diseases.

Read More: Depression News and Depression Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.